Redona Therapeutics
Ed is the Director of Finance and Operations at Twentyeight-Seven. Ed has over 25 years’ experience managing finance and operations teams, including senior finance roles in the architecture, engineering, and professional services industry. Ed is a licensed CPA and a member of the AICPA and the VSCPA, and received a BBA in Finance from the University of Notre Dame.
This person is not in any offices
Redona Therapeutics
Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.